1 Alcohol consumption in India- An epidemiological review.

2 Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis.

3 Polyphenolic Profile and Antioxidant Activity of Leaf Purified Hydroalcoholic Extracts from Seven Mexican Cultivars.

4 Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.

5 Probiotics for Alleviating Alcoholic Liver Injury.

6 Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis.

7 Effects of Hydroalcoholic Extract of Tanacetum Sonbolii (Asteraceae) on Pain-related Behaviors during Formalin Test in Mice

8 Circ_1639 induces cells inflammation responses by sponging miR-122 and regulating TNFRSF13C expression in alcoholic liver disease.

9 Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease.

10 A Mediterranean Diet Rich in Extra-Virgin Olive Oil Is Associated with a Reduced Prevalence of Nonalcoholic Fatty Liver Disease in Older Individuals at High Cardiovascular Risk.

11 Supervisory System and Multivariable Control Applying Weighted Fuzzy-PID Logic in an Alcoholic Fermentation Process

12 An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US

13 An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US

14 Evaluation of diffusion kurtosis imaging in stratification of nonalcoholic fatty liver disease and early diagnosis of nonalcoholic steatohepatitis in a rabbit model.

15 Photoacoustic gas monitoring for anesthetic gas pollution measurements and its cross-sensitivity to alcoholic disinfectants.

16 Augmented intelligence with natural language processing applied to electronic health records for identifying patients with non-alcoholic fatty liver disease at risk for disease progression.

17 Pharmacognostic studies and nephroprotective potential of hydroalcoholic extract of trichosanthes cucumerina in acute renal failure

18 Association Between Nonalcoholic Fatty Liver Disease and Severe Male Reproductive Organ Impairment (Germinal Epithelial Loss): Study on a Mouse Model and on Human Patients

19 Reduction of some atherogenic indices in patients with non-alcoholic fatty liver by Vitamin D and calcium co-supplementation: A double blind randomized controlled clinical trial

20 Age-Related Alterations of Nonalcoholic Steatohepatitis in Sprague-Dawley Rats Fed a High-Fat and High-Cholesterol Diet.

21 [Involvement of the Free Fatty Acid Receptor GPR120/FFAR4 in the Development of Nonalcoholic Steatohepatitis].

22 [Inhibition of Group IVA Phospholipase A as a Novel Therapeutic Strategy for Nonalcoholic Steatohepatitis].

23 [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].

24 Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease

25 Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease

26 Erratum: Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease (Cell Metabolism (2017) 25(5) (1054–1062.e5), (S1550413117302061), (10.1016/j.cmet.2017.04.001))

27 Neutrophil-to-lymphocyte ratio is independently associated with inflammatory activity and fibrosis grade in nonalcoholic fatty liver disease

28 Validation Study of Elastographies in Patients With Nonalcoholic Fatty Liver Disease for Detecting Liver Fibrosis

29 Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis

30 The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease

31 Curcumin: Reintroduced Therapeutic Agent from Traditional Medicine for Alcoholic Liver Disease

32 Estrogen-related receptor γ controls sterol regulatory element-binding protein-1c expression and alcoholic fatty liver.

33 Raw Bowl Tea (Tuocha) Polyphenol Prevention of Nonalcoholic Fatty Liver Disease by Regulating Intestinal Function in Mice.

34 The life history of an ex-alcoholic with an evaluation of factors involved in causation and rehabilitation.

35 BURDEN OF ALCOHOL IN PATIENTS WITH ALCOHOLIC LIVER DISEASE [ALD] AND THEIR FAMILIES IN ODISHA

36 TRIB1 rs17321515 gene polymorphism increases the risk of coronary heart disease in general population and non-alcoholic fatty liver disease patients in Chinese Han population.

37 Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls.

38 Understanding alcoholism through microRNA signatures in brains of human alcoholics

39 Hepatic Mitochondrial Defects in a Nonalcoholic Fatty Liver Disease Mouse Model Are Associated with Increased Degradation of Oxidative Phosphorylation Subunits.

40 Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease

41 Nonalcoholic Fatty Liver Disease in South Asia.

42 Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial.

43 Individualized exercise prescription in non-alcoholic steatohepatitis: a case report

44 The effect of hydroalcoholic extract of Urtica dioica on morphine withdrawal signs in male mice

45 Uniqueness of Ethiopian traditional alcoholic beverage of plant origin, tella

46 Investigating the effect of L. petal hydroalcoholic extract on inflammatory and enzymatic indices resulting from alcohol use in kidney and liver of male rats.

47 Effect of Hydroalcoholic Extract of on Acute Hypertension Induced by L-NAME in Rat.

48 Isolation and Identification of HFY05 from Natural Fermented Yak Yogurt and Its Effect on Alcoholic Liver Injury in Mice.

49 Plants in alcoholic beverages on the Croatian islands, with special reference to rakija travarica.

50 Whole Grain Consumption and Its Effects on Hepatic Steatosis and Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.

51 Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population

52 Intermediary effect of inflammation on the association between dietary patterns and non-alcoholic fatty liver disease.

53 Lifestyle Intervention Framework for Obese Patients with Non-alcoholic Fatty Liver Disease - a Tool for Health Professionals in Resource Constraint Settings.

54 Fat and sugar—a dangerous duet. A comparative review on metabolic remodeling in rodent models of nonalcoholic fatty liver disease

55 Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease

56 NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.

57 Neural and psychological characteristics of college students with alcoholic parents differ depending on current alcohol use.

58 [Major hypokalemia with rhabdomyolysis secondary to the intake of a nonalcoholic aniseed aperitif].

59 Asporin levels are low in patients with nonalcoholic fatty liver disease and increase after vitamin E treatment.

60 Nonalcoholic steatohepatitis: A scientometric analysis of publications during 1980-2018.

61 In vivo analgesic, antipyretic, and anti-inflammatory potential in Swiss albino mice and in vitro thrombolytic activity of hydroalcoholic extract from Litsea glutinosa leaves.

62 Evaluation of In Vivo Antidiarrheal Activities of Hydroalcoholic Leaf Extract of L.(Sapindaceae) in Swiss Albino Mice.

63 Evaluation of In Vivo Antidiarrheal Activities of Hydroalcoholic Leaf Extract of Dodonaea viscosa L.(Sapindaceae) in Swiss Albino Mice

64 IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis.

65 A STUDY OF METABOLIC PARAMETERS IN NON DIABETIC PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE - IMPORTANCE OF DYSLIPIDEMIA.

66 New dual peroxisome proliferator activated receptor agonist - Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: Integrated analysis of the real world evidence

67 Copper modulates sex-specific fructose hepatoxicity in nonalcoholic fatty liver disease (NALFD) Wistar rat models.

68 Melissa officinalis L. hydro-alcoholic extract inhibits anxiety and depression through prevention of central oxidative stress and apoptosis.

69 A highly selective acridine-based fluorescent probe for detection of Al in alcoholic beverage samples.

70 [1,2,5]Oxadiazolo[3,4-b]pyrazine-5,6-diamine Derivatives as Mitochondrial Uncouplers for the Potential Treatment of Nonalcoholic Steatohepatitis.

71 Adipocytokine Regulation and Antiangiogenic Activity Underlie the Molecular Mechanisms of Therapeutic Effects of Phyllanthus niruri against Non-Alcoholic Fatty Liver Disease.

72 Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model.

73 Regulation of CD39 expression in ATP-P2Y2R-mediated alcoholic liver steatosis and inflammation

74 Incretin combination therapy for the treatment of non-alcoholic steatohepatitis.

75 Investigating effect of Helicobacter pylori treatment on improvement of non-alcoholic fatty liver parameters: a randomized trial

76 Potential implications of COVID-19 in non-alcoholic fatty liver disease.

77 Effect of Hydro-alcoholic Extract from Prosopis Farcta Leaves on Liver Injury Caused by High-fat Diet in Rats

78 Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials

79 The effect of green tea extract supplementation on liver enzymes in patients with nonalcoholic fatty liver disease

80 Monocapas de ácidos grasos. III. Ácidos palmítico, láurico y oleico sobre disoluciones acuosas que contienen solutos con grupos funcionales alcohólicos

81 Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats.

82 Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease

83 Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease

84 Antioxidant Vitamins and Brain Dysfunction in Alcoholics

85 Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets

86 Active Helicobacter pylori Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients

87 Active Helicobacter pylori Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients

88 Psoralea corylifolia L. Seed Extract Attenuates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice

89 Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease

90 Antioxidant vitamins and brain dysfunction in alcoholics

91 Pathogenesis of Alcoholic Liver Disease

92 Alcoholic liver disease: pathogenesis and new targets for therapy

93 THE THERAPEUTIC IMPACT OF PROBIOTICS ON NONALCOHOLIC FATTY LIVER DISEASE IN PEDIATRICS: A SYSTEMATIC REVIEW

94 obese children with metabolic syndrome have 3 times higher risk to have nonalcoholic fatty liver disease compared with those without metabolic syndrome

95 investigating the deregulation of metabolic tasks via minimum network enrichment analysis (minea) as applied to nonalcoholic fatty liver disease using mouse and human omics data.

96 bariatric surgery and nonalcoholic fatty liver disease: current and potential future treatments

97 ft3/ft4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism

98 the effects of hydro alcoholic extract of dorema aucheri on blood concentration of gonadotropin and androgen hormones in adult male rats

99 the state of pancreatobiliary system and intestinal microflora in children with nonalcoholic fatty liver disease

100 the effect of hydroalcoholic extract of juglans regia l. leaf on blood pressure and its interaction with adrenergic system of male rats

101 how useful are monogenic rodent models for the study of human non-alcoholic fatty liver disease?

Keyword Connections

Journals

Research Groups

Bibliographies